OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002876 Shenzhen Sunnypol Optoelectronics
- 27.16
- +0.80+3.03%
Not Open Apr 1 15:00 CST
4.72BMarket Cap69.29P/E (TTM)
27.47High26.29Low64.31KlotVolume26.36Open26.36Pre Close174.42MTurnover4.32%Turnover Ratio69.29P/E (Static)173.88MShares34.0152wk High2.00P/B4.05BFloat Cap17.8352wk Low29.00Limit Up148.95MShs Float74.58Historical High23.72Limit Down4.48%Amplitude11.78Historical Low0.03Dividend TTM27.12Avg Price25.95KlotAsk0.09%Div YieldTTM100Lot Size34.59KlotBid
Shenzhen Sunnypol Optoelectronics Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.77%1.91B | 8.16%1.43B | 3.65%870.37M | -6.80%292.71M | -13.95%1.94B | -17.41%1.33B | -23.94%839.73M | -36.29%314.05M | 0.99%2.26B | -3.04%1.61B |
| Refunds of taxes and levies | --10.19M | 872.95%10.19M | 1,958.35%9.05M | ---- | ---- | -98.17%1.05M | -98.95%439.74K | -18.80%439.74K | 1,175.83%56.87M | 2,631.26%57.09M |
| Cash received relating to other operating activities | -46.59%109.5M | -30.77%12.76M | -14.52%10.53M | 1,305.52%36.97M | 14.30%205.02M | -83.31%18.43M | -87.40%12.32M | -96.16%2.63M | 219.85%179.37M | 236.61%110.38M |
| Cash inflows from operating activities | -5.57%2.03B | 8.30%1.46B | 4.39%889.95M | 3.96%329.68M | -13.88%2.15B | -24.11%1.35B | -31.46%852.49M | -43.57%317.12M | 8.62%2.49B | 4.87%1.77B |
| Goods services cash paid | -2.37%1.4B | 10.46%1.21B | 15.78%718.71M | 0.61%288.33M | -9.44%1.44B | -9.25%1.09B | -23.89%620.77M | -28.57%286.58M | 11.25%1.59B | 6.61%1.2B |
| Staff behalf paid | 4.16%351.42M | 6.03%257.42M | 7.10%172.13M | 5.85%92.81M | 2.70%337.4M | 0.33%242.79M | -5.67%160.71M | -9.78%87.68M | 13.98%328.53M | 19.99%241.99M |
| All taxes paid | -14.01%79.71M | -50.76%38.43M | -69.10%10.38M | 21.02%17.67M | -32.20%92.69M | -33.94%78.06M | -53.58%33.58M | -67.08%14.6M | -28.63%136.72M | -12.47%118.16M |
| Cash paid relating to other operating activities | -36.86%149.47M | 12.59%196.05M | 80.20%156.06M | 206.99%116.25M | 580.27%236.73M | 41.23%174.13M | 18.92%86.6M | 12.33%37.87M | -83.72%34.8M | -34.25%123.3M |
| Cash outflows from operating activities | -5.72%1.98B | 7.00%1.7B | 17.26%1.06B | 20.70%515.06M | 0.80%2.1B | -5.91%1.59B | -20.29%901.67M | -25.97%426.73M | -1.56%2.09B | 2.04%1.69B |
| Net cash flows from operating activities | 1.70%42.21M | 0.26%-239.55M | -240.26%-167.32M | -69.13%-185.37M | -89.73%41.5M | -373.51%-240.18M | -143.67%-49.18M | -660.53%-109.6M | 133.19%404.25M | 123.53%87.81M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | -98.97%76.65K | -98.84%76.65K | -98.20%76.65K | -97.30%76.65K | -31.19%7.42M | -20.68%6.59M | -36.98%4.25M | --2.84M | 7.72%10.78M | --8.31M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -97.25%3.9K | ---- | ---- | ---- | --141.84K | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | -92.89%70M | -91.57%70M | -87.50%70M | -80.56%70M | -17.90%985.21M | 3.75%830M | -6.67%560M | --360M | 30.43%1.2B | 45.45%800M |
| Cash inflows from investing activities | -92.94%70.08M | -91.62%70.08M | -87.58%70.08M | -80.69%70.08M | -18.01%992.77M | 3.50%836.59M | -7.00%564.25M | --362.84M | 30.09%1.21B | 46.97%808.31M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -29.22%480.52M | -16.46%264.35M | -2.16%185.28M | 120.54%93.04M | 169.93%678.89M | 125.21%316.43M | 189.05%189.37M | -0.08%42.19M | 76.47%251.51M | 25.52%140.5M |
| Cash paid to acquire investments | 4,361.54%58M | --53.5M | --52.5M | --52M | --1.3M | ---- | ---- | ---- | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --47.75M |
| Cash paid relating to other investing activities | -86.83%82.93M | -87.21%72.9M | -84.49%72.9M | -77.91%72.9M | -46.19%629.61M | -28.75%570M | -21.67%470M | --330M | -0.81%1.17B | 23.08%800M |
| Cash outflows from investing activities | -52.55%621.45M | -55.92%390.75M | -52.88%310.68M | -41.44%217.94M | -7.86%1.31B | -10.30%886.43M | -7.56%659.37M | 781.51%372.19M | 7.52%1.42B | 29.70%988.25M |
| Net cash flows from investing activities | -73.92%-551.37M | -543.45%-320.67M | -152.95%-240.61M | -1,482.48%-147.86M | -50.45%-317.03M | 72.30%-49.84M | 10.70%-95.12M | 77.87%-9.34M | 46.15%-210.72M | 15.10%-179.94M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | --49K | --49K | --49K | --49K | ---- | --0 |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | --49K | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 41.74%2.61B | 60.43%2.32B | 37.31%1.27B | 135.96%936M | 6.53%1.84B | -4.70%1.45B | -8.18%927.37M | 68.19%396.68M | 1.15%1.73B | 6.45%1.52B |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.89%6.46M | --6.46M |
| Cash inflows from financing activities | 41.74%2.61B | 60.43%2.32B | 37.30%1.27B | 135.93%936M | 6.14%1.84B | -5.10%1.45B | -8.76%927.42M | 68.21%396.73M | -1.12%1.74B | 6.90%1.53B |
| Borrowing repayment | 26.25%2.02B | 30.12%1.68B | -11.82%811.11M | 24.28%476.16M | -15.24%1.6B | -18.13%1.29B | -14.68%919.88M | -24.44%383.14M | 24.64%1.89B | 18.86%1.58B |
| Dividend interest payment | -32.19%38.61M | -24.55%35.08M | -51.15%21.29M | 115.21%8.26M | -33.58%56.94M | -38.67%46.5M | -38.29%43.58M | -49.62%3.84M | 48.52%85.73M | 81.05%75.82M |
| Cash payments relating to other financing activities | 1,477.17%78.08M | 1,539.57%72.47M | 1,800.10%67.52M | --27.33M | -91.48%4.95M | --4.42M | --3.55M | ---- | 38.77%58.13M | --0 |
| Cash outflows from financing activities | 28.57%2.14B | 33.19%1.79B | -6.94%899.92M | 32.25%511.76M | -18.20%1.66B | -18.81%1.34B | -15.82%967.02M | -24.81%386.98M | 25.86%2.03B | 17.94%1.65B |
| Net cash flows from financing activities | 161.36%478.36M | 413.96%531.98M | 1,043.08%373.47M | 4,249.54%424.24M | 162.38%183.02M | 179.68%103.51M | 70.06%-39.6M | 103.50%9.75M | -304.19%-293.38M | -656.75%-129.91M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 137.89%16.35M | -3,053.66%-7.78M | -554.58%-4.22M | -393.59%-984.35K | -9.24%6.87M | 86.82%-246.55K | 147.67%928.84K | 380.14%335.28K | 146.30%7.57M | 24.56%-1.87M |
| Net increase in cash and cash equivalents | 83.12%-14.46M | 80.71%-36.02M | 78.86%-38.68M | 182.70%90.02M | 7.21%-85.63M | 16.59%-186.76M | -42.82%-182.97M | 67.56%-108.86M | -29.58%-92.29M | -47.50%-223.9M |
| Add:Begin period cash and cash equivalents | -25.85%245.63M | -25.85%245.63M | -25.85%245.63M | -25.85%245.63M | -21.79%331.27M | -21.79%331.27M | -21.79%331.27M | -64.98%331.27M | -14.39%423.55M | -14.39%423.55M |
| End period cash equivalent | -5.89%231.18M | 45.06%209.61M | 39.55%206.95M | 50.92%335.66M | -25.85%245.63M | -27.62%144.51M | -49.80%148.3M | -63.57%222.41M | -21.79%331.27M | -41.79%199.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.